Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
Pralidoxime chloride is an oxime-based antidote administered via autoinjector in intramuscular solution form for rapid delivery. It is indicated for treatment of organophosphate pesticide or nerve agent poisoning by reactivating acetylcholinesterase. The autoinjector formulation enables rapid emergency administration in field or hospital settings.
Product is in late-stage lifecycle with limited commercial growth, suggesting smaller team footprint and focus on operational efficiency rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on pralidoxime offers career stability in a specialized emergency-care niche with predictable, low-volume commercial requirements. Roles tend toward regulatory maintenance, safety stewardship, and operational management rather than commercial growth or innovation, making this suitable for professionals seeking specialized expertise in toxicology or emergency medicine.
Worked on PRALIDOXIME CHLORIDE (AUTOINJECTOR) at CooperSurgical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.